Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
The Pathophysiology, Diagnosis, and Treatment of Dry Eye Disease
Countries citing papers authored by Elisabeth M. Messmer
Since
Specialization
Citations
This map shows the geographic impact of Elisabeth M. Messmer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisabeth M. Messmer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisabeth M. Messmer more than expected).
Fields of papers citing papers by Elisabeth M. Messmer
This network shows the impact of papers produced by Elisabeth M. Messmer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisabeth M. Messmer. The network helps show where Elisabeth M. Messmer may publish in the future.
Co-authorship network of co-authors of Elisabeth M. Messmer
This figure shows the co-authorship network connecting the top 25 collaborators of Elisabeth M. Messmer.
A scholar is included among the top collaborators of Elisabeth M. Messmer based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Elisabeth M. Messmer. Elisabeth M. Messmer is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Messmer, Eli sa beth M., Andrea Leonardi, Mourad Amrane, et al.. (2016). Pooling of two randomized Phase III clinical trials of ciclosporin 1 mg/mL cationic emulsion (CsA CE) as a treatment for severe keratitis in patients with dry eye disease (DED). Investigative Ophthalmology & Visual Science. 57(12). 2871–2871.1 indexed citations
11.
Messmer, Eli sa beth M., et al.. (2014). Matrix-Metalloproteinase-9 (MMP-9) - Testing in Dry Eye Syndrome. Investigative Ophthalmology & Visual Science. 55(13). 2001–2001.1 indexed citations
12.
Messmer, Eli sa beth M., et al.. (2012). Osmolarity in Patients with Meibomian Gland Dysfunction (MGD). Investigative Ophthalmology & Visual Science. 53(14). 556–556.2 indexed citations
13.
Mackert, Marc J., Daniel Zapp, Anselm Kampik, & Eli sa beth M. Messmer. (2005). Conjunctival Tumors Evaluated by in vivo Confocal Microscopy. Investigative Ophthalmology & Visual Science. 46(13). 1079–1079.1 indexed citations
14.
Messmer, Eli sa beth M., Daniel Zapp, Marc J. Mackert, Martin Thiel, & Anselm Kampik. (2005). In vivo Confocal Microscopy of Filtering Blebs Following Trabeculectomy. Investigative Ophthalmology & Visual Science. 46(13). 1218–1218.1 indexed citations
15.
Messmer, Eli sa beth M., et al.. (2000). Okuläres vernarbendes Pemphigoid : Retrospektive Analyse von Risikofaktoren und Komplikationen. Der Ophthalmologe. 97(2). 113–120.9 indexed citations
16.
Messmer, Eli sa beth M., Michael B. Raizman, & C. Stephen Foster. (1998). Lepromatous uveitis diagnosed by iris biopsy. Graefe s Archive for Clinical and Experimental Ophthalmology. 236(9). 717–719.8 indexed citations
17.
Messmer, Eli sa beth M., et al.. (1993). [Treatment of age-associated macular degeneration with interferon-alfa-2a].. PubMed. 90(3). 279–82.1 indexed citations
Messmer, Eli sa beth M.. (1954). Clinical Assessment of Industrial Lead Poisoning.. Medizinische Klinik - Intensivmedizin und Notfallmedizin. 49(6).1 indexed citations
20.
Messmer, Eli sa beth M.. (1954). [Clinical expert opinion on occupational lead poisoning].. PubMed. 49(6). 218–23.2 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.